AbCellera Biologics Inc (NASDAQ: ABCL) is -11.60% lower on its value in year-to-date trading and has touched a low of $2.11 and a high of $4.75 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABCL stock was last observed hovering at around $2.44 in the last trading session, with the day’s gains setting it 0.15%.
Currently trading at $2.59, the stock is 4.78% and -10.35% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.75 million and changing 6.15% at the moment leaves the stock -9.11% off its SMA200. ABCL registered -45.24% loss for a year compared to 6-month gain of -5.47%. The firm has a 50-day simple moving average (SMA 50) of $2.8889 and a 200-day simple moving average (SMA200) of $2.84965.
The stock witnessed a -14.52% loss in the last 1 month and extending the period to 3 months gives it a -3.72%, and is 1.97% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.86% over the week and 7.03% over the month.
AbCellera Biologics Inc (ABCL) has around 596 employees, a market worth around $771.79M and $28.83M in sales. Profit margin for the company is -564.81%. Distance from 52-week low is 22.75% and -45.47% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.58%).
with sales reaching $7.12M over the same period.The EPS is expected to shrink by -10.53% this year, but quarterly earnings will post -8.82% year-over-year. Quarterly sales are estimated to shrink -28.43% in year-over-year returns.
AbCellera Biologics Inc (ABCL) Top Institutional Holders
200.0 institutions hold shares in AbCellera Biologics Inc (ABCL), with institutional investors hold 55.07% of the company’s shares. The shares outstanding are 295.76M, and float is at 223.58M with Short Float at 8.90%. Institutions hold 42.47% of the Float.
The top institutional shareholder in the company is BAKER BROS. ADVISORS LP with over 27.53 million shares valued at $81.48 million. The investor’s holdings represent 9.3556% of the ABCL Shares outstanding. As of 2024-06-30, the second largest holder is BAILLIE GIFFORD & CO with 21.91 million shares valued at $$64.86 million to account for 7.4472 of the shares outstanding. The other top investors are VOYA INVESTMENT MANAGEMENT LLC which holds 10.62 million shares representing 3.611% and valued at over $31.45 million, while CAPITAL WORLD INVESTORS holds 1.8078 of the shares totaling 5.32 million with a market value of $15.74 million.
AbCellera Biologics Inc (ABCL) Insider Activity
#####
